MedImmune announced it has begun shipping FluMist (influenza vaccine live, intranasal) for the 2012-2013 influenza season. MedImmune expects to provide approximately 13 million doses of FluMist through private health care practices, public health departments, school-located vaccination programs, military bases, retail pharmacies and other venues.
FluMist is a trivalent, live attenuated influenza vaccine (virus types A and B) indicated for active immunization for healthy persons 2–49 years of age. FluMist Quadrivalent (influenza vaccine live, intranasal), approved February 2012, will be available for the 2013-2014 influenza season.
For more information call (877) 633-4411 or visit www.flumist.com.